Blood biomarker points to increased risk of brain metastasis in patients with inflammatory breast cancer

Researchers at The University of Texas MD Anderson Cancer Center have identified a targetable driver of brain metastases in patients with aggressive inflammatory breast cancer. The study uncovers a novel role for soluble E-cadherin (sEcad) in…

Continue Reading

News Source: medicalxpress.com